1-(2-Nitro-4-(trifluoromethyl)phenyl)ethan-1-one, 97%, 1g

3-Bromophenylboronic acid, 98.0%, 5g

(1S,2S)-2-Methylcyclopropanecarboxylic acid, 97%, 5g

Ethyl 6-methoxypyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 250mg

(S)-(3-Aminopyrrolidin-1-yl)(2-fluorophenyl)methanone, 95.0%, 1g

Trityl-glycine, 95.0%, 100g

4-(3-Chloro-propyl)-morpholine, 97.0%, 500g

5-(chloromethyl)-3-(2-methoxyethyl)-1,2,4-oxadiazole, 95.0%, 1g

PCR individual vials Mμlti®, colorless, 500 µl 1000 pcs

(R)-4-(Iodomethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 250mg

Ethyl 4-(4-Methoxy-3-methylphenyl)-4-oxobutanoate, 97.0%, 1g

2-(2-((2,6-Dichlorophenyl)amino)-5-hydroxyphenyl)acetic acid, 98.00%, 100mg

Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate, 98%, 25g